202 related articles for article (PubMed ID: 12146015)
21. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
22. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
23. Cerebrovascular accident during cisplatin-based combination chemotherapy of testicular germ cell tumor: an unusual case report.
Azak A; Oksüzoğlu B; Deren T; Oneç BM; Zengin N
Anticancer Drugs; 2008 Jan; 19(1):97-8. PubMed ID: 18043135
[TBL] [Abstract][Full Text] [Related]
24. Gonadal function in patients with testicular germ cell tumors.
Tomomasa H; Oshio S; Ashizawa Y; Kamiyama Y; Okano Y; Iiyama T; Sato S; Shimizu H; Umeda T
Arch Androl; 2002; 48(6):405-15. PubMed ID: 12425758
[TBL] [Abstract][Full Text] [Related]
25. [Effect of extensiveness of testicular germinoma on the choice of a treatment regimen].
Gorelov AI; Bogdanova EO; Komiakova BK
Vopr Onkol; 2003; 49(4):455-8. PubMed ID: 14569936
[TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.
Chevreau C; Mazerolles C; Soulié M; Gaspard MH; Mourey L; Bujan L; Plante P; Rischmann P; Bachaud JM; Malavaud B
Eur Urol; 2004 Aug; 46(2):209-14; discussion 214-5. PubMed ID: 15245815
[TBL] [Abstract][Full Text] [Related]
27. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
[TBL] [Abstract][Full Text] [Related]
28. [Effects of chemotherapy and radiotherapy of malignant testicular tumors on residual testicular tissue].
Barth V; Büttner W
Z Urol Nephrol; 1990 Jul; 83(7):367-72. PubMed ID: 2238878
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy for good-risk germ-cell tumors.
Ryan CJ; Bajorin DF
Semin Urol Oncol; 2002 Nov; 20(4):244-50. PubMed ID: 12489057
[TBL] [Abstract][Full Text] [Related]
30. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.
Geldart TR; Gale J; McKendrick J; Kirby J; Mead G
BJU Int; 2006 Aug; 98(2):353-8. PubMed ID: 16879677
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer.
Gerl A; Schierl R
Acta Oncol; 2000; 39(4):519-22. PubMed ID: 11041115
[TBL] [Abstract][Full Text] [Related]
32. Brain metastasis from non-seminomatous germ cell tumor of the testis.
Forquer JA; Harkenrider M; Fakiris AJ; Timmerman RD; Cavaliere R; Henderson MA; Lo SS
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1567-80. PubMed ID: 18020925
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular risk in long-term survivors of testicular cancer.
Vaughn DJ; Palmer SC; Carver JR; Jacobs LA; Mohler ER
Cancer; 2008 May; 112(9):1949-53. PubMed ID: 18338810
[TBL] [Abstract][Full Text] [Related]
34. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors.
Eskicorapci SY; Ekici S; Atsu MN; Dogan R; Ozen H
Int J Urol; 2004 Aug; 11(8):634-9. PubMed ID: 15285754
[TBL] [Abstract][Full Text] [Related]
35. Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer: are there implications for blood pressure management in patients receiving chemotherapy?
Kohli S; Kohli M
J Clin Oncol; 2006 May; 24(15):2399; author reply 2399-400. PubMed ID: 16710045
[No Abstract] [Full Text] [Related]
36. Two cycles of cisplatin-based chemotherapy for low-volume retroperitoneal stage II nonseminomatous germ cell tumours.
Steiner H; Müller T; Gozzi C; Akkad T; Bartsch G; Berger AP
BJU Int; 2006 Aug; 98(2):349-52. PubMed ID: 16626306
[TBL] [Abstract][Full Text] [Related]
37. Left ventricular and cardiac autonomic function in survivors of testicular cancer.
Nuver J; Smit AJ; Sleijfer DT; van Gessel AI; van Roon AM; van der Meer J; van den Berg MP; Hoekstra HJ; Sluiter WJ; Gietema JA
Eur J Clin Invest; 2005 Feb; 35(2):99-103. PubMed ID: 15667580
[TBL] [Abstract][Full Text] [Related]
38. Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer.
Petersen PM; Hansen SW; Giwercman A; Rørth M; Skakkebaek NE
Ann Oncol; 1994 Apr; 5(4):355-8. PubMed ID: 8075033
[TBL] [Abstract][Full Text] [Related]
39. Late complications of chemotherapy in testicular cancer.
Pliarchopoulou K; Pectasides D
Cancer Treat Rev; 2010 May; 36(3):262-7. PubMed ID: 20092952
[TBL] [Abstract][Full Text] [Related]
40. Advances in the management of non-seminomatous germ cell tumors during the cisplatin era: a single-institution experience.
Muramaki M; Hara I; Miyake H; Yamada Y; Kawabata G; Kamidono S
Int J Urol; 2004 Sep; 11(9):768-73. PubMed ID: 15379942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]